Management of Hereditary Hemochromatosis
Hereditary hemochromatosis is primarily managed by internists and primary care physicians, with referral to hepatologists or gastroenterologists for complex cases involving advanced liver disease, and to hematologists when specialized iron disorder expertise is needed. 1
Primary Management by Internists and Primary Care Physicians
The American College of Physicians explicitly identifies internists and other primary care physicians as the target audience for hereditary hemochromatosis management guidelines. 1 These physicians are responsible for:
Initial case-finding using serum ferritin and transferrin saturation testing in patients with suggestive symptoms (fatigue, joint pain, elevated liver enzymes, diabetes, cardiac arrhythmias, skin pigmentation changes, or family history). 1
Ordering and interpreting genetic testing after appropriate counseling about risks, benefits, and limitations (including insurance implications and psychological impact). 1
Initiating and monitoring therapeutic phlebotomy, which is the cornerstone of treatment. Weekly or biweekly phlebotomy (approximately 500 mL) should be performed until ferritin reaches the target of 50-100 µg/L, followed by maintenance phlebotomy at individualized intervals. 2, 3
Monitoring hematocrit/hemoglobin before each phlebotomy to ensure decline does not exceed 20% of baseline, and rechecking ferritin after every 10-12 sessions. 3
When to Refer to Specialists
Hepatology/Gastroenterology Referral
Refer to a hepatologist or gastroenterologist when:
Serum ferritin exceeds 1,000 µg/L or liver enzymes are persistently elevated, as liver biopsy may be needed to assess for cirrhosis and quantify hepatic iron concentration. 4, 3
Cirrhosis is confirmed or suspected, because these patients require hepatocellular carcinoma surveillance every 6 months (ultrasound ± alpha-fetoprotein) regardless of iron depletion status. 2, 3
Advanced fibrosis (METAVIR F3 or higher) is present, as HCC screening may be indicated even without frank cirrhosis. 2
Decompensated cirrhosis develops, requiring evaluation for orthotopic liver transplantation. 3
Hematology or Iron Disorder Specialist Referral
Refer to a hematologist or iron disorder specialist when:
Significant unexplained iron overload is present without typical HFE mutations (C282Y homozygosity or C282Y/H63D compound heterozygosity). 2, 3
Young patients present with severe manifestations (liver disease, amenorrhea, hypogonadism, cardiomyopathy) suggesting juvenile hemochromatosis or rare gene variants (HJV, HAMP, TfR2). 2
Phlebotomy is contraindicated or not tolerated, requiring consideration of iron chelation therapy (though evidence is weak and deferasirox is not approved for hemochromatosis by European regulators and should not be used in advanced liver disease). 2
Cardiology Referral
Refer to cardiology when:
Cardiac symptoms, arrhythmias, or heart failure are present, as cardiac complications are the most common cause of sudden death in iron overload and may worsen during rapid iron mobilization. 3
Cardiac MRI for myocardial iron quantification is needed, particularly in patients with severe hemochromatosis or juvenile hemochromatosis. 2
Endocrinology Referral
Consider endocrinology referral for:
Diabetes management in patients with "bronze diabetes," as pancreatic β-cell damage is largely irreversible and most patients require ongoing insulin therapy despite iron removal. 3
Hypogonadism evaluation and management, as testicular iron deposition does not improve with phlebotomy. 3
Common Pitfalls in Specialist Selection
Do not delay phlebotomy while awaiting specialist consultation if biochemical evidence of iron overload is present; early treatment by the primary care physician prevents irreversible organ damage. 3
Do not assume normal liver enzymes exclude cirrhosis; approximately 50% of cirrhotic hemochromatosis patients have normal ALT/AST levels. 3
Do not refer all patients with elevated ferritin to hepatology; those with ferritin <1,000 µg/L and normal liver enzymes can proceed directly to therapeutic phlebotomy under primary care management. 4, 3
Multidisciplinary Coordination
For patients with established complications (cirrhosis, diabetes, cardiomyopathy, arthropathy), a coordinated approach involving primary care as the central coordinator with subspecialty input optimizes outcomes. 2, 3 Primary care physicians maintain responsibility for phlebotomy monitoring and family screening, while specialists address organ-specific complications. 1, 2